Assessment of Opioid-Prescribing Practices in Breast Augmentation: Future Directions for Prescribing Guidelines.
Journal
Annals of plastic surgery
ISSN: 1536-3708
Titre abrégé: Ann Plast Surg
Pays: United States
ID NLM: 7805336
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
pubmed:
23
6
2020
medline:
15
5
2021
entrez:
23
6
2020
Statut:
ppublish
Résumé
The United States (US) is in the mid of an opioid epidemic propagated, in part, by prescription opioids. With excess overprescribing documented in a variety of surgical procedures, several societies have recommended opioid-prescribing guidelines. Considering the scope and postoperative pain associated with aesthetic plastic surgery procedures, earnest evaluation into opioid-prescribing practices for breast augmentation was conducted. Members of the American Society for Aesthetic Plastic Surgery were electronically surveyed on their opioid-prescribing patterns. The survey was distributed to 1709 plastic surgeons. Descriptive statistics were collated into percentages, deviations, and morphine milligram equivalents (MMEs), when appropriate. Two hundred twenty-nine American Society for Aesthetic Plastic Surgery members (13.4%) provided responses. A total of 91.2% of respondents prescribe opioids to patients undergoing breast augmentation. The most commonly prescribed agents included oxycodone/acetaminophen (Percocet, 47.0%) and hydrocodone/acetaminophen (Vicodin, 38.3%). On average, 165.3 ± 81.7 MMEs were dispensed (range, 25.0-600.0 MMEs; number tablets, 5-60). Prescribers felt that a lack of phone-in prescribing (52.4%) and the ease of preemptively prescribing opioids (52.4%) propagate opioid overprescribing. A total of 61.3% of respondents reported that they are or may be in favor of developing plastic surgery societal guidelines related to opioid prescribing. These respondents indicated support for guidelines on opioid-sparing pain management strategies (74.2%) and guidelines identifying the type (54.7%), duration of use (69.5%), and number of opioid tablets (61.7%) necessary for procedures. Considerable variability exists among prescribing patterns after breast augmentation. Societal guidelines aimed at providers and patients may serve a future role in opioid prescribing.
Sections du résumé
BACKGROUND
The United States (US) is in the mid of an opioid epidemic propagated, in part, by prescription opioids. With excess overprescribing documented in a variety of surgical procedures, several societies have recommended opioid-prescribing guidelines. Considering the scope and postoperative pain associated with aesthetic plastic surgery procedures, earnest evaluation into opioid-prescribing practices for breast augmentation was conducted.
METHODS
Members of the American Society for Aesthetic Plastic Surgery were electronically surveyed on their opioid-prescribing patterns. The survey was distributed to 1709 plastic surgeons. Descriptive statistics were collated into percentages, deviations, and morphine milligram equivalents (MMEs), when appropriate.
RESULTS
Two hundred twenty-nine American Society for Aesthetic Plastic Surgery members (13.4%) provided responses. A total of 91.2% of respondents prescribe opioids to patients undergoing breast augmentation. The most commonly prescribed agents included oxycodone/acetaminophen (Percocet, 47.0%) and hydrocodone/acetaminophen (Vicodin, 38.3%). On average, 165.3 ± 81.7 MMEs were dispensed (range, 25.0-600.0 MMEs; number tablets, 5-60). Prescribers felt that a lack of phone-in prescribing (52.4%) and the ease of preemptively prescribing opioids (52.4%) propagate opioid overprescribing. A total of 61.3% of respondents reported that they are or may be in favor of developing plastic surgery societal guidelines related to opioid prescribing. These respondents indicated support for guidelines on opioid-sparing pain management strategies (74.2%) and guidelines identifying the type (54.7%), duration of use (69.5%), and number of opioid tablets (61.7%) necessary for procedures.
CONCLUSIONS
Considerable variability exists among prescribing patterns after breast augmentation. Societal guidelines aimed at providers and patients may serve a future role in opioid prescribing.
Identifiants
pubmed: 32568754
doi: 10.1097/SAP.0000000000002430
pii: 00000637-202101000-00005
doi:
Substances chimiques
Analgesics, Opioid
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
11-18Références
Centers for Disease Control and Prevention. 2018 Annual Surveillance Report of Drug-Related Risks and Outcomes - United States. Available at: https://www.cdc.gov/drugoverdose/pdf/pubs/2018-cdc-drug-surveillance-report.pdf . Accessed May 5, 2019.
Scholl L, Seth P, Kariisa M, et al. Drug and opioid-involved overdose deaths - United States, 2013-2017. MMWR Morb Mortal Wkly Rep . 2018;67:1419–1427.
Wood E. Strategies for reducing opioid-overdose deaths - lessons from Canada. N Engl J Med . 2018;378:1565–1567.
Ossiander EM. Using textual cause-of-death data to study drug poisoning deaths. Am J Epidemiol . 2014;179:884–894.
Seth P, Rudd RA, Noonan RK, et al. Quantifying the epidemic of prescription opioid overdose deaths. Am J Public Health . 2018;108:500–502.
Larach DB, Waljee JF, Hu H-M, et al. Patterns of initial opioid prescribing to opioid-naive patients. Ann Surg . 2020;271:290–295.
Neuman MD, Bateman BT, Wunsch H. Inappropriate opioid prescription after surgery. Lancet . 2019;393:1547–1557.
Thiels CA, Anderson SS, Ubl DS, et al. Wide variation and overprescription of opioids after elective surgery. Ann Surg . 2017;266:564–573.
Wunsch H, Wijeysundera DN, Passarella MA, et al. Opioids prescribed after low-risk surgical procedures in the United States, 2004-2012. JAMA . 2016;315:1654–1657.
Bicket MC, Long JJ, Pronovost PJ, et al. Prescription opioid analgesics commonly unused after surgery: a systematic review. JAMA Surg . 2017;152:1066–1071.
Hill MV, Stucke RS, Billmeier SE, et al. Guideline for discharge opioid prescriptions after inpatient general surgical procedures. J Am Coll Surg . 2018;226:996–1003.
Michigan Opioid Prescribing Engagement Network. Opioid Prescribing Recommendations for Surgery. Available at: https://opioidprescribing.info/ . Accessed May 16, 2019.
Rose KR, Christie BM, Block LM, et al. Opioid prescribing and consumption patterns following outpatient plastic surgery procedures. Plast Reconstr Surg . 2019;143:929–938.
Hart AM, Broecker JS, Kao L, et al. Opioid use following outpatient breast surgery: are physicians part of the problem? Plast Reconstr Surg . 2018;142:611–620.
Patel S, Sturm A, Bobian M, et al. Opioid use by patients after rhinoplasty. JAMA Facial Plast Surg . 2018;20:24–30.
Bennett KG, Harbaugh CM, Hu HM, et al. Persistent opioid use among children, adolescents, and young adults after common cleft operations. J Craniofac Surg . 2018;29:1697–1701.
Johnson SP, Chung KC, Zhong L, et al. Risk of prolonged opioid use among opioid-naïve patients following common hand surgery procedures. J Hand Surg Am . 2016;41:947–957.e3.
Marcusa DP, Mann RA, Cron DC, et al. Prescription opioid use among opioid-naive women undergoing immediate breast reconstruction. Plast Reconstr Surg . 2017;140:1081–1090.
American Society for Aesthetic Plastic Surgery. Top 5 procedures: surgical & nonsurgical. Available at: https://www.surgery.org/sites/default/files/ASAPS-Stats2018-Top-5.pdf . Accessed June 05, 2019.
Opioid oral morphine milligram equivalent (MME) conversion factors. Available at: https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/Downloads/Opioid-Morphine-EQ-Conversion-Factors-Aug-2017.pdf . Accessed May 25, 2019.
Schaeffer CV, Dassoulas KR, Thuman J, et al. Early functional outcomes after prepectoral breast reconstruction: a case-matched cohort study. Ann Plast Surg . 2019;82:S399–S403.
Copeland-Halperin LR, Yemc L, Emery E, et al. Evaluating postoperative narcotic use in prepectoral versus dual-plane breast reconstruction following mastectomy. Plast Reconstr Surg Glob Open . 2019;7:e2082.
Peirce GL, Smith MJ, Abate MA, et al. Doctor and pharmacy shopping for controlled substances. Med Care . 2012;50:494–500.
Park TW, Saitz R, Ganoczy D, et al. Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study. BMJ . 2015;350:h2698.
Sun EC, Dixit A, Humphreys K, et al. Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis. BMJ . 2017;356:j760.
Jones CM, McAninch JK. Emergency department visits and overdose deaths from combined use of opioids and benzodiazepines. Am J Prev Med . 2015;49:493–501.
Kelley BP, Bennett KG, Chung KC, et al. Ibuprofen may not increase bleeding risk in plastic surgery: a systematic review and meta-analysis. Plast Reconstr Surg . 2016;137:1309–1316.
Walker NJ, Jones VM, Kratky L, et al. Hematoma risks of nonsteroidal anti-inflammatory drugs used in plastic surgery procedures: a systematic review and meta-analysis. Ann Plast Surg . 2019;82:S437–s445.
Mitchell A, McCrea P, Inglis K, et al. A randomized, controlled trial comparing acetaminophen plus ibuprofen versus acetaminophen plus codeine plus caffeine (Tylenol 3) after outpatient breast surgery. Ann Surg Oncol . 2012;19:3792–3800.
Chen T, Adamson PA. Comparison of ibuprofen and acetaminophen with codeine following cosmetic facial surgery. J Otolaryngol Head Neck Surg . 2009;38:580–586.
Gupta A, Jakobsson J. Acetaminophen, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 selective inhibitors: an update. Plast Reconstr Surg . 2014;134:24s–31s.
Nalamachu S. An overview of pain management: the clinical efficacy and value of treatment. Am J Manag Care . 2013;19:s261–s266.
Blondell RD, Azadfard M, Wisniewski AM. Pharmacologic therapy for acute pain. Am Fam Physician . 2013;87:766–772.
Hill MV, McMahon ML, Stucke RS, et al. Wide variation and excessive dosage of opioid prescriptions for common general surgical procedures. Ann Surg . 2017;265:709–714.
Kaafarani HM, Weil E, Wakeman S, et al. The opioid epidemic and new legislation in Massachusetts: time for a culture change in surgery? Ann Surg . 2017;265:731–733.
Gawande AA. It's time to adopt electronic prescriptions for opioids. Ann Surg . 2017;265:693–694.
Gabriel MH, Swain M. E-prescribing trends in the United States. Available at: http://healthitgov.ahrqstg.org/sites/default/files/oncdatabriefe-prescribingincreases2014.pdf . Accessed May 29, 2019.
Agency, D. E. Electronic prescriptions for controlled substances. Available at: https://www.federalregister.gov/documents/2010/03/31/2010-6687/electronic-prescriptions-for-controlled-substances . Accessed May 29, 2019.
Davis CS, Lieberman AJ, Hernandez-Delgado H, et al. Laws limiting the prescribing or dispensing of opioids for acute pain in the United States: a national systematic legal review. Drug Alcohol Depend . 2019;194:166–172.
National Conference of State Legislators. Prescribing policies: states confront opioid overdose epidemic. Available at: http://www.ncsl.org/research/health/prescribing-policies-states-confront-opioid-overdose-epidemic.aspx . Accessed May 28, 2019.
Hill MV, Stucke RS, McMahon ML, et al. An educational intervention decreases opioid prescribing after general surgical operations. Ann Surg . 2018;267:468–472.
Lee JS, Howard RA, Klueh MP, et al. The impact of education and prescribing guidelines on opioid prescribing for breast and melanoma procedures. Ann Surg Oncol . 2019;26:17–24.
Dwyer CL, Soong M, Hunter A, et al. Prospective evaluation of an opioid reduction protocol in hand surgery. J Hand Surg Am . 2018;43:516–522.e1.
Stepan JG, Sacks HA, Lovecchio FC, et al. Opioid prescriber education and guidelines for ambulatory upper-extremity surgery: evaluation of an institutional protocol. J Hand Surg Am . 2019;44:129–136.
Culbertson G, Rosenfield L. Managing the chronic pain cosmetic patient & prevention of opioid overdosing. Available at: https://www.surgery.org/professionals/patient-safety/safety-protocols . Accessed May 26, 2019 2019.
Schairer WW, Kahlenberg CA, Sculco PK, et al. What is the quality of online resources about pain control after total knee arthroplasty? J Arthroplasty . 2017;32:3616–3620.e1.
Kumar G, Jaremko KM, Kou A, et al. Quality of patient education materials on safe opioid management in the acute perioperative period: what do patients find online? Pain Med . 2020;21:171–175.
Wallace LS, Keenum AJ, Roskos SE. Comprehensibility and readability of patient self-administered opioid assessment screening tools. J Opioid Manag . 2007;3:338–344.
McCarthy DM, Wolf MS, McConnell R, et al. Improving patient knowledge and safe use of opioids: a randomized controlled trial. Acad Emerg Med . 2015;22:331–339.
Rose P, Sakai J, Argue R, et al. Opioid information pamphlet increases postoperative opioid disposal rates: a before versus after quality improvement study. Can J Anaesth . 2016;63:31–37.
Syed UAM, Aleem AW, Wowkanech C, et al. Neer award 2018: the effect of preoperative education on opioid consumption in patients undergoing arthroscopic rotator cuff repair: a prospective, randomized clinical trial. J Shoulder Elbow Surg . 2018;27:962–967.
Waszak DL, Mitchell AM, Ren D, et al. A quality improvement project to improve education provided by nurses to ED patients prescribed opioid analgesics at discharge. J Emerg Nurs . 2018;44:336–344.
Oyler D, Bernard AC, VanHoose JD, et al. Minimizing opioid use after acute major trauma. Am J Health Syst Pharm . 2018;75:105–110.
Torabi R, Bourn L, Mundinger GS, et al. American society of plastic surgeons member post-operative opioid prescribing patterns. Plast Reconstr Surg Glob Open . 2019;7:e2125.